Last reviewed · How we verify
Gingivitis — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Exidine | CHLORHEXIDINE | Molnlycke Hlth | chlorhexidine | Solute carrier family 22 member 1 | 1976-01-01 | |
| Chlorhexidin | Chlorhexidin | Krishnadevaraya College of Dental Sciences & Hospital | Synaptojanin-2, 72 kDa type IV collagenase, Matrix metalloproteinase-9 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Krishnadevaraya College of Dental Sciences & Hospital · 1 drug in Gingivitis
- Molnlycke Hlth · 1 drug in Gingivitis
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Gingivitis:
- Gingivitis treatment updates — RSS
- Gingivitis treatment updates — Atom
- Gingivitis treatment updates — JSON
Cite this brief
Drug Landscape (2026). Gingivitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/gingivitis. Accessed 2026-06-09.
Related
- Gingivitis full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing